Clifford Chance has advised Tillotts Pharma AG on the deal. Tillotts Pharma AG agreed to acquire the rights to the drug DIFICLIRTM™ from Astellas Pharma Europe…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
